Research & policy
Focused on research and policy to advance evidence-based approaches and shape a responsible path forward.
Building how psychedelic therapies reach people
Building how psychedelic therapies reach people.
From research to real-world care.
Beckley Waves was founded in 2020 to build the care delivery infrastructure for the emerging field of psychedelic-assisted therapies.
It was co-founded by Amanda Feilding, Rock Feilding-Mellen and Daniel Love, and forms part of Amanda Feilding’s broader life’s work — helping to shape the modern psychedelic renaissance across three complementary domains.
Drug development
Advancing the development of psychedelic medicines to unlock their therapeutic potential at scale.(Merged into Atai Beckley Inc in November 2025.)
Care delivery & access
Building the infrastructure and models of care to ensure safe, effective and equitable access to these therapies.
Together, these efforts span the pathway from scientific discovery to real-world impact.
Our role
While most capital and attention have concentrated on research and drug development, Beckley Waves is focused on an equally critical question:
How would psychedelic and adjacent therapies reach people safely, effectively, and at scale?
Structured as a holding company, Beckley Waves co-founds and incubates or invests in companies to answer that question — building the models through which psychedelic-assisted care is delivered in the real world.
Our portfolio
Beckley Waves’ portfolio reflects its understanding that psychedelic medicines are powerful tools, not panaceas in themselves; they are a gateway to deeper inner work, through which real health, meaning and flourishing become possible; but they need to be treated with care and reverence, and individuals going through the gateway can benefit greatly from expert support they trust. Our portfolio companies are specifically designed to provide just such support for individuals and groups, wherever they are at along the continuum from healing to thriving.
Healing
Building the new model of care delivery and reimbursement needed for interventional psychiatry to revolutionize behavioral healthcare in the US.
Everyday wellbeing
A digital platform offering accessible, at-home experiences for meditation, insight, and expanded awareness.
Deep personal development
The leading provider of legal psychedelic wellbeing programs, supporting better health and human flourishing beyond traditional medical models.
Vision
A future in which psychedelic therapies usher in a new paradigm for human health, and are responsibly integrated into society — unlocking new possibilities for mental health, personal growth, and human flourishing.